Ana Rovira

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations

David Tamborero, Carlota Rubio-Pérez, Jordi Deu-Pons et al. · Genome Medicine · 2018 · 558 citations · Full text

Medicine, Bioinformatics, Oncology +16

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

Clara Montagut, Alba Dalmases, Beatríz Bellosillo et al. · Nature Medicine · 2012 · 506 citations

Medicine, Oncology, Pharmacology +16

Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer

Sabrina Arena, Beatríz Bellosillo, Giulia Siravegna et al. · Clinical Cancer Research · 2015 · 275 citations · Full text

Medicine, Oncology, Pharmacology +13

Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer

Federico Rojo, Jetzabel García-Parra, Sandra Zazo et al. · Annals of Oncology · 2011 · 179 citations · Full text

Veterinary Medicine, Molecular Biology, Oncology +9

Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity

Josep Domingo‐Domenech, Cristina Oliva, Ana Rovira et al. · Clinical Cancer Research · 2006 · 169 citations

Medicine, Oncology, Pharmacology +17